Byron Nash Renal Medullary Carcinoma Awareness Act of 2019

United States116th CongressHR-148House of Representatives
Updated: Jan 25, 2019

Summary

Byron Nash Renal Medullary Carcinoma Awareness Act of 2019 This bill allows states to receive federal payment under Medicaid for 50% of their costs for providing education on the risk of renal medullary carcinoma to individuals with sickle cell disease. (Renal medullary carcinoma is a rare kidney disease usually found in individuals with the sickle cell trait.)

Bill texts

Available versions
Introduced (House)View official text

1 version available

All available records shown.

Timeline

  1. Referred to the House Committee on Energy and Commerce.

    House of Representatives

  2. Introduced in House

  3. Referred to the Subcommittee on Health.

    House of Representatives

All available records shown.